ASHLEY DAVES: Open Payments
NPI 1366498099 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 21 payments from 8 companies in 2025. Trend: 2023 $513 · 2024 $565 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $149 |
| Novo Nordisk Inc | 3 | $74 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| PFIZER INC. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $20 |
Products named: FARXIGA, NEXLETOL, AIRSUPRA, PREVNAR 20, XIFAXAN, Ozempic, GEMTESA, ELIQUIS.
Industry payments across TN — which companies pay providers there.
